内容紹介
Summary
A 59-year-old woman who complained of melena and lightheadedness visited the outpatient clinic at our hospital. According to her blood test result, she had anemia, and her tumor marker levels were high. Enhanced computed tomography(CT)findings showed small intestinal cancer with multiple liver metastases. Partial resection of the small bowel for the small intestinal cancer was performed. Following the administration of fourth-line outpatient chemotherapy containing S-1 plus irinotecan(IRIS)and IRIS plus bevacizumab(IRIS plus Bev), S-1 plus oxaliplatin plus Bev(SOX plus Bev), and weekly paclitaxel(wPAC), she survived with good condition for 19 months after the surgery.
要旨
症例は59歳,女性。下血,ふらつきを主訴に当科を受診となった。高度貧血と腫瘍マーカーの上昇を認め,腹部造影CTにて多発肝転移を伴う小腸癌と診断した。小腸部分切除術を施行した。病理組織診断は高分化型腺癌であった。術後からS-1+irinotecan(IRIS)併用療法,IRIS+bevacizumab(IRIS+Bev)併用療法,S-1+oxaliplatin+Bev(SOX+Bev)併用療法,weekly paclitaxel(wPAC)療法とfourth-lineまで化学療法を施行し得たが,1年7か月後に原病死となった。
目次
A 59-year-old woman who complained of melena and lightheadedness visited the outpatient clinic at our hospital. According to her blood test result, she had anemia, and her tumor marker levels were high. Enhanced computed tomography(CT)findings showed small intestinal cancer with multiple liver metastases. Partial resection of the small bowel for the small intestinal cancer was performed. Following the administration of fourth-line outpatient chemotherapy containing S-1 plus irinotecan(IRIS)and IRIS plus bevacizumab(IRIS plus Bev), S-1 plus oxaliplatin plus Bev(SOX plus Bev), and weekly paclitaxel(wPAC), she survived with good condition for 19 months after the surgery.
要旨
症例は59歳,女性。下血,ふらつきを主訴に当科を受診となった。高度貧血と腫瘍マーカーの上昇を認め,腹部造影CTにて多発肝転移を伴う小腸癌と診断した。小腸部分切除術を施行した。病理組織診断は高分化型腺癌であった。術後からS-1+irinotecan(IRIS)併用療法,IRIS+bevacizumab(IRIS+Bev)併用療法,S-1+oxaliplatin+Bev(SOX+Bev)併用療法,weekly paclitaxel(wPAC)療法とfourth-lineまで化学療法を施行し得たが,1年7か月後に原病死となった。